1. Home
  2. KRRO vs ULBI Comparison

KRRO vs ULBI Comparison

Compare KRRO & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • ULBI
  • Stock Information
  • Founded
  • KRRO 2014
  • ULBI 1990
  • Country
  • KRRO United States
  • ULBI United States
  • Employees
  • KRRO N/A
  • ULBI N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • ULBI Industrial Machinery/Components
  • Sector
  • KRRO Health Care
  • ULBI Miscellaneous
  • Exchange
  • KRRO Nasdaq
  • ULBI Nasdaq
  • Market Cap
  • KRRO 101.4M
  • ULBI 98.1M
  • IPO Year
  • KRRO 2019
  • ULBI 1992
  • Fundamental
  • Price
  • KRRO $12.35
  • ULBI $8.21
  • Analyst Decision
  • KRRO Strong Buy
  • ULBI Strong Buy
  • Analyst Count
  • KRRO 7
  • ULBI 1
  • Target Price
  • KRRO $85.67
  • ULBI $14.00
  • AVG Volume (30 Days)
  • KRRO 203.4K
  • ULBI 127.1K
  • Earning Date
  • KRRO 08-12-2025
  • ULBI 07-24-2025
  • Dividend Yield
  • KRRO N/A
  • ULBI N/A
  • EPS Growth
  • KRRO N/A
  • ULBI N/A
  • EPS
  • KRRO N/A
  • ULBI 0.31
  • Revenue
  • KRRO $4,821,000.00
  • ULBI $173,275,000.00
  • Revenue This Year
  • KRRO $65.08
  • ULBI $31.30
  • Revenue Next Year
  • KRRO N/A
  • ULBI $6.24
  • P/E Ratio
  • KRRO N/A
  • ULBI $26.11
  • Revenue Growth
  • KRRO N/A
  • ULBI 2.74
  • 52 Week Low
  • KRRO $10.29
  • ULBI $4.07
  • 52 Week High
  • KRRO $98.00
  • ULBI $12.40
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 41.55
  • ULBI 70.78
  • Support Level
  • KRRO $11.50
  • ULBI $7.37
  • Resistance Level
  • KRRO $16.86
  • ULBI $8.53
  • Average True Range (ATR)
  • KRRO 1.50
  • ULBI 0.42
  • MACD
  • KRRO 0.01
  • ULBI 0.02
  • Stochastic Oscillator
  • KRRO 31.35
  • ULBI 81.16

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Share on Social Networks: